Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2018)
18 slides from Coloplast A/s Class B's investor day presentation, 2018
Slide 1: Wound Care update
Wound Care update Coloplast Capital Markets Day 2018 Nicolai Buhl Andersen, Senior Vice President Wound & Skin Care
Slide 2: We continue to invest in and execute on our strategy for Wound Care
We continue to invest in and execute on our strategy for Wound Care Shape the Endorsements Publications standard Build a strong product PIP portfolio Accelerate in Ramp-up EU Strengthen New structure New New position in the management Investment plan US Secure leading position Revised targeting Leve
Slide 3: The global Wound Care market remains a highly attractive value pool of DKK ~40bn
The global Wound Care market remains a highly attractive value pool of DKK ~40bn… Wound Care global market Market size in DKKbn 18-201 10-12 8-10 Advanced Wound Care NPWT Biologics Source: Coloplast estimates 1) Coloplast’s addressable market • . Page 3
Slide 4: Advanced Wound Care segment represents a DKK 18-20bn opportunity growing 2-4%
… and the Advanced Wound Care segment alone represents a DKK 18-20bn opportunity growing 2-4% Advanced Wound Care (AWC) market value Market drivers / limiters + Ageing population (People above 60 expected to double by 2050, reaching ~2bn)1 Emerging + Growing prevalence of diabetes Markets (Number of
Slide 5: To succeed in AWC, you need to play and win in Silicone foams and Antimicrobials
To be successful in the AWC segment, you need to play and win in Silicone foams and Antimicrobials Wound Care market category breakdown DKK 5-7bn DKK 3-5bn 5-7% growth 2-4% growth Silicone Antimicrobials Non-Silicone Contact Alginates & Hydrocolloids Other Foams Foams Layers Hydrofibers Source: Colo
Slide 6: To be clinically relevant, you need a conforming dressing
To be clinically relevant in Silicone foams and Antimicrobials, you need a conforming dressing… References: Adderley UJ (2010) Managing wound exudate and promoting healing. Br J Community Nurs 15(3): S15–6, 18, 20. Doc. No. PM-02934 Mouës CM, Heule F, Legerstee R, Hovius SE (2009) Five millennia of
Slide 7: To be clinically relevant, you need a conforming dressing
To be clinically relevant in Silicone foams and Antimicrobials, you need a conforming dressing… Gaps create space for Pools of exudate promote If exudate leaks onto the wound exudate pooling bacterial growth leading to the edges and periwound skin, it will risk of infection become macerated and may
Slide 8: Not all foams are the same: Biatain Silicone stands out with 3DFit Technology
… not all foams are the same… Biatain® Silicone stands out with 3DFit® Technology Biatain® Silicone conforms to the wound … better than our main competitors… … therefore we have launched… bed… Biatain® Silicone Competitor 1 Competitor 2 Conforms to wound bed ~ 70% of customers perceive Absorbs verti
Slide 9: 3DFit Technology proven clinically relevant for both non-infected and infected wounds
3DFit Technology proven clinically relevant for both non- infected and infected wounds Biatain® Silicone for non-infected wounds… … and Biatain® Silicone Ag for infected wounds Kills mature biofilms2 Study with Biatain® Silicone shows1: 0% & 0% Prevents biofilms formation2 Maceration Exudate pooling
Slide 10: Launch of 3DFit Technology and Sizes & Shapes has improved Biatain Silicone momentum
Launch of 3DFit Technology and Sizes & Shapes has improved our Biatain® Silicone momentum Biatain Silicone growth trend Revenue growth (MAT vs. last year) 3DFit Technology launch Silicone Foams market growth, 5-7% Oct Nov Dec Jan Feb Mar Apr May Jun 2017/18 Source: Coloplast • . Page 10
Slide 11: We are well-positioned to tap into the key segments in the Wound Care market
We are well-positioned to tap into the key segments in the Wound Care market • . Page 11
Slide 12: Introducing Wound and Skin Care
Introducing Wound and Skin Care Wound Care is the core part of our business… … and Europe is the main market Revenue split, FY 16/17 Revenue split, FY 16/17 2.1 2.1 billion of DKK billion of DKK annual revenue annual revenue Wound Care Europe Skin Care Other Developed Markets Contract manufacturing
Slide 13: Performance picture impacted by external headwinds mainly in China, France and Greece
Performance picture impacted by external headwinds mainly in China, France and Greece Global Wound Care Organic revenue growth 15/16-YTD 17/18 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 15/16 16/17 17/18 Source: Coloplast • . Page 13
Slide 14: In Europe, we are pleased with the overall performance picture and outgrow the market
In Europe, we are pleased with the overall performance picture, and significantly outgrow the market Coloplast Europe WC growth vs. market growth We outgrow the market in all countries Revenue growth (MAT vs. LY) Market growth 1-2% Oct Oct Oct 15/16 16/17 17/18 Source: Coloplast •
Slide 15: In the US, we have launched a new setup, new portfolio and new evidence
In the US, we have launched a new setup, new portfolio and new evidence to make a difference New team, … new offering to win in both … and supporting evidence2 structure, plan… treatment and prevention… Redistributes pressure Manages microclimate Winning in US is both Peak Pressure Moisture Vapor Tr
Slide 16: In Emerging markets, China remains key and we are expanding our position
In Emerging markets, China remains a key market and we are expanding our position in other markets China remains a critical market… In Emerging markets we are selectively investing in next wave markets • A growing and attractive market • We have a strong market position with high share-of-voice Aust
Slide 17: Conclusion and summary
Conclusion and summary Victor We still see attractive value creation opportunities within the 1. Wound Care market We are investing in our Wound Care business, and we are fully 2. executing on our strategic priorities Although we have faced some external headwinds, we are 3. taking share in key prod
Slide 18: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast Group - Ostomy Care /